{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:20:29Z","timestamp":1783948829932,"version":"3.55.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.imbio.2021.152148","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T16:22:41Z","timestamp":1635178961000},"page":"152148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Immunomodulatory role of Th17 pathway in experimental visceral leishmaniasis"],"prefix":"10.1016","volume":"226","author":[{"given":"Rasmita","family":"Khatonier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giasuddin","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallab","family":"Sarmah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanwar","family":"Narain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Mabood","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.imbio.2021.152148_b0005","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PloS ONE"},{"key":"10.1016\/j.imbio.2021.152148_b0010","doi-asserted-by":"crossref","first-page":"10706","DOI":"10.1038\/srep10706","article-title":"Genetically engineered ascorbic acid-deficient live mutants of Leishmania donovani induce long lasting protective immunity against visceral leishmaniasis","volume":"5","author":"Anand","year":"2015","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.imbio.2021.152148_b0015","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.4049\/jimmunol.1003588","article-title":"IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis","volume":"186","author":"Ansari","year":"2011","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.imbio.2021.152148_b0020","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/506624","article-title":"Interferon (IFN)-\u03b3, tumor necrosis factor-\u03b1, interleukin-6, and IFN-\u03b3 receptor 1 are the major immunological determinants associated with post-Kala Azar dermal leishmaniasis","volume":"194","author":"Ansari","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.imbio.2021.152148_b0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2332\/allergolint.R-07-159","article-title":"Th17 Cells and autoimmune encephalomyelitis (EAE\/MS)","volume":"57","author":"Aranami","year":"2008","journal-title":"Allergol. Int."},{"issue":"1","key":"10.1016\/j.imbio.2021.152148_b0030","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1038\/s41598-017-04595-8","article-title":"Anti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance","volume":"7","author":"Ara\u00fajo-Santos","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.imbio.2021.152148_b0035","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1086\/599380","article-title":"Interleukin 17 production among patients with American cutaneous leishmaniasis","volume":"200","author":"Bacellar","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"7090","key":"10.1016\/j.imbio.2021.152148_b0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.imbio.2021.152148_b0045","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1002\/eji.200940115","article-title":"Human mucosal leishmaniasis: neutrophils infiltrate areas of tissue damage that express high levels of Th17-related cytokines","volume":"40","author":"Boaventura","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.imbio.2021.152148_b0050","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.4049\/jimmunol.177.7.4636","article-title":"Inhibition of IL-2 induced IL-10 production as a principle of phase-specific immunotherapy","volume":"177","author":"Bodas","year":"2006","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2021.152148_b0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2334-5-113","article-title":"Balance of IL-10 and interferon-\u03b3 plasma levels in human visceral leishmaniasis: implications in the pathogenesis","volume":"5","author":"Caldas","year":"2005","journal-title":"BMC Infect. Dis."},{"issue":"10","key":"10.1016\/j.imbio.2021.152148_b0060","doi-asserted-by":"crossref","first-page":"e0004179","DOI":"10.1371\/journal.pntd.0004179","article-title":"Cytokine release assays as tests for exposure to Leishmania, and for confirming cure from leishmaniasis, in solid organ transplant recipients","volume":"9","author":"Carrillo","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"6","key":"10.1016\/j.imbio.2021.152148_b0070","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.immuni.2011.10.018","article-title":"Th17 cells mediate clade-specific, serotype-independent mucosal immunity","volume":"35","author":"Chen","year":"2011","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.imbio.2021.152148_b0075","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1590\/S0074-02762012000600005","article-title":"Cytokines and visceral leishmaniasis: a comparison of plasma cytokine profiles between the clinical forms of visceral leishmaniasis","volume":"107","author":"Costa","year":"2012","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"6","key":"10.1016\/j.imbio.2021.152148_b0085","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.parint.2016.07.005","article-title":"Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system","volume":"65","author":"Duarte","year":"2016","journal-title":"Parasitol. Int."},{"issue":"2","key":"10.1016\/j.imbio.2021.152148_b0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00436-007-0469-z","article-title":"Antileishmanial potential of a marine sponge, Haliclona exigua (Kirkpatrick) against experimental visceral leishmaniasis","volume":"101","author":"Dube","year":"2007","journal-title":"Parasitol. Res."},{"issue":"1","key":"10.1016\/j.imbio.2021.152148_b0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41541-017-0025-5","article-title":"A defined subunit vaccine that protects against vector-borne visceral leishmaniasis","volume":"2","author":"Duthie","year":"2017","journal-title":"NPJ Vaccines"},{"issue":"11","key":"10.1016\/j.imbio.2021.152148_b0100","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.pt.2004.08.009","article-title":"Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis","volume":"20","author":"Engwerda","year":"2004","journal-title":"Trends Parasitol."},{"issue":"7","key":"10.1016\/j.imbio.2021.152148_b0105","doi-asserted-by":"crossref","first-page":"e2914","DOI":"10.1371\/journal.pntd.0002914","article-title":"Immune regulation during chronic visceral leishmaniasis","volume":"8","author":"Faleiro","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"6","key":"10.1016\/j.imbio.2021.152148_b0110","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/infdis\/jis771","article-title":"Successful therapy of visceral leishmaniasis with curdlan involves T-helper 17 cytokines","volume":"207","author":"Ghosh","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"26","key":"10.1016\/j.imbio.2021.152148_b0115","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1016\/j.vaccine.2015.12.071","article-title":"Status of vaccine research and development of vaccines for leishmaniasis","volume":"34","author":"Gillespie","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.imbio.2021.152148_b0120","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.4049\/jimmunol.164.4.2001","article-title":"TGF-\u03b2 mediates CTLA-4 suppression of cellular immunity in murine kalaazar","volume":"164","author":"Gomes","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2021.152148_b0125","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3389\/fimmu.2017.01437","article-title":"The equivocal role of Th17 cells and neutrophils on immunopathogenesis of Leishmaniasis","volume":"8","author":"Gon\u00e7alves-de-Albuquerque","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2021.152148_b0130","doi-asserted-by":"crossref","unstructured":"Gonzalez-Lombana C., Gimblet C., Bacellar O., Oliveira W.W., Passos S., Carvalho L.P., Goldschmidt M., Carvalho E.M., Scott P., 2013. IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection. PLoS Pathog. 9(3):e1003243.","DOI":"10.1371\/journal.ppat.1003243"},{"issue":"9","key":"10.1016\/j.imbio.2021.152148_b0135","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.4049\/jimmunol.170.9.4432","article-title":"Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection","volume":"170","author":"Happel","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2021.152148_b0140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2172-14-52","article-title":"Analysis of localized immune responses reveals presence of Th17 and Treg cells in cutaneous leishmaniasis due to Leishmania tropica","volume":"14","author":"Katara","year":"2013","journal-title":"BMC Immunol."},{"issue":"4","key":"10.1016\/j.imbio.2021.152148_b0145","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s12639-018-1025-8","article-title":"Role of IL-21 in host pathogenesis in experimental visceral leishmaniasis","volume":"42","author":"Khatonier","year":"2018","journal-title":"J. Parasitic Dis."},{"issue":"1","key":"10.1016\/j.imbio.2021.152148_b0150","doi-asserted-by":"crossref","first-page":"e1006165","DOI":"10.1371\/journal.ppat.1006165","article-title":"Transcriptional profiling in experimental visceral leishmaniasis reveals a broad splenic inflammatory environment that conditions macrophages toward a disease-promoting phenotype","volume":"13","author":"Kong","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.imbio.2021.152148_b0155","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.2741\/4052","article-title":"Th17 related cytokines in acute myeloid leukemia","volume":"17","author":"Li","year":"2012","journal-title":"Front. Biosci."},{"issue":"5","key":"10.1016\/j.imbio.2021.152148_b0160","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.4049\/jimmunol.0713598","article-title":"IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice","volume":"182","author":"Lopez Kostka","year":"2009","journal-title":"J. Immunol."},{"issue":"24","key":"10.1016\/j.imbio.2021.152148_b0165","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1016\/j.febslet.2009.10.036","article-title":"Correlation of mRNA and protein in complex biological samples","volume":"583","author":"Maier","year":"2009","journal-title":"FEBS Lett."},{"issue":"7090","key":"10.1016\/j.imbio.2021.152148_b0170","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-\u03b2 induces development of the TH17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.imbio.2021.152148_b0175","doi-asserted-by":"crossref","first-page":"e818","DOI":"10.1371\/journal.pntd.0000818","article-title":"Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent","volume":"4","author":"Meheus","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"3","key":"10.1016\/j.imbio.2021.152148_b0180","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4049\/jimmunol.166.3.1912","article-title":"The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response","volume":"166","author":"Melby","year":"2001","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.imbio.2021.152148_b0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/jof3040052","article-title":"The role of IL-17 in protection against mucosal candida infections","volume":"3","author":"Mengesha","year":"2017","journal-title":"J. Fungi"},{"issue":"10","key":"10.1016\/j.imbio.2021.152148_b0190","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/eji.200838535","article-title":"Induction, function and regulation of IL-17-producing T cells","volume":"38","author":"Mills","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.imbio.2021.152148_b0195","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11739-011-0517-7","article-title":"The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases","volume":"6","author":"Murdaca","year":"2011","journal-title":"Int. Emerg. Med."},{"issue":"8","key":"10.1016\/j.imbio.2021.152148_b0200","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.4049\/jimmunol.174.8.4916","article-title":"Prevention of relapse after chemotherapy in a chronic intracellular infection: mechanisms in experimental visceral leishmaniasis","volume":"174","author":"Murray","year":"2005","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.imbio.2021.152148_b0205","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1128\/IAI.68.11.6289-6293.2000","article-title":"Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment","volume":"68","author":"Murray","year":"2000","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.imbio.2021.152148_b0210","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1086\/376510","article-title":"Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis","volume":"188","author":"Murray","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.imbio.2021.152148_b0215","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1128\/IAI.70.11.6284-6293.2002","article-title":"Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy","volume":"70","author":"Murray","year":"2002","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.imbio.2021.152148_b0220","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1128\/AAC.47.8.2513-2517.2003","article-title":"Immunoenhancement combined with amphotericin B as treatment for experimental visceral leishmaniasis","volume":"47","author":"Murray","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.imbio.2021.152148_b0225","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/AAC.45.8.2185-2197.2001","article-title":"Clinical and experimental advances in treatment in visceral leishmaniasis","volume":"45","author":"Murray","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.imbio.2021.152148_b0230","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/infdis\/jiu531","article-title":"Interleukin 17A acts synergistically with interferon \u03b3 to promote protection against Leishmania infantum infection","volume":"211","author":"Nascimento","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imbio.2021.152148_b0235","unstructured":"National Road Map for Kala-azar Elimination. Delhi: Directorate of National Vector Borne Disease Control Programme (NVBDCP), Directorate General of Health Services, Minister of Health & Family Welfare; 2014. Available from http:\/\/nvbdcp.gov.in\/Doc\/ Annual-report-NVBDCP-2014-15.pdf."},{"issue":"5","key":"10.1016\/j.imbio.2021.152148_b0240","doi-asserted-by":"crossref","first-page":"e0005527","DOI":"10.1371\/journal.pntd.0005527","article-title":"A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH","volume":"11","author":"Osman","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.imbio.2021.152148_b0245","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1128\/IAI.70.1.62-68.2002","article-title":"Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination","volume":"70","author":"Papadopoulou","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.imbio.2021.152148_b0255","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jneuroim.2011.09.013","article-title":"Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse","volume":"240-241","author":"Peelen","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.imbio.2021.152148_b0260","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.4049\/jimmunol.1201676","article-title":"Evaluation of recombinant Leishmania polyprotein plus glucopyranosyl lipid A stable emulsion vaccines against sand fly-transmitted Leishmania major in C57BL\/6 mice","volume":"189","author":"Peters","year":"2012","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.imbio.2021.152148_b0265","first-page":"2379","article-title":"IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani","volume":"119","author":"Pitta","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.imbio.2021.152148_b0270","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1128\/IAI.00283-16","article-title":"Interleukin-27 (IL-27) mediates susceptibility to visceral leishmaniasis by suppressing the IL-17-neutrophil response","volume":"84","author":"Quirino","year":"2016","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.imbio.2021.152148_b0275","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.4049\/jimmunol.179.6.3988","article-title":"Neutrophils activate macrophages for intracellular killing of Leishmania major through recruitment of TLR4 by neutrophil elastase","volume":"179","author":"Ribeiro-Gomes","year":"2007","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.imbio.2021.152148_b0280","doi-asserted-by":"crossref","first-page":"e0155224","DOI":"10.1371\/journal.pone.0155224","article-title":"Compartmentalized immune response in leishmaniasis: Changing patterns throughout the disease","volume":"11","author":"Rodr\u00edguez-Cort\u00e9s","year":"2016","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.imbio.2021.152148_b0285","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4049\/jimmunol.0900265","article-title":"Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis","volume":"183","author":"Samant","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2021.152148_b0290","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.624009","article-title":"Role of cytokines in experimental and human visceral leishmaniasis","volume":"11","author":"Samant","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"31","key":"10.1016\/j.imbio.2021.152148_b0295","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1016\/j.vaccine.2014.05.009","article-title":"Generation of growth arrested Leishmania amastigotes: a tool to develop live attenuated vaccine candidates against visceral leishmaniasis","volume":"32","author":"Selvapandiyan","year":"2014","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.imbio.2021.152148_b0300","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.4049\/jimmunol.1501046","article-title":"IL-17A\u2013producing \u03b3\u03b4 T cells suppress early control of parasite growth by monocytes in the liver","volume":"195","author":"Sheel","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2021.152148_b0305","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fimmu.2014.00296","article-title":"Immunotherapy and targeted therapies in treatment of visceral leishmaniasis: current status and future prospects","volume":"5","author":"Singh","year":"2014","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.imbio.2021.152148_b0310","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/380971","article-title":"Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations","volume":"38","author":"Sundar","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.imbio.2021.152148_b0320","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/14787210.2018.1532790","article-title":"Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence","volume":"16","author":"Sundar","year":"2018","journal-title":"Expert. Rev. Anti Infect. Ther."},{"issue":"3","key":"10.1016\/j.imbio.2021.152148_b0325","first-page":"345","article-title":"Visceral leishmaniasis-current therapeutic modalities","volume":"123","author":"Sundar","year":"2006","journal-title":"Indian J. Med. Res."},{"issue":"3","key":"10.1016\/j.imbio.2021.152148_b0330","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1096\/fj.15-277202","article-title":"IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani","volume":"30","author":"Terrazas","year":"2015","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.imbio.2021.152148_b0335","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00628.x","article-title":"Th17 cells in human disease","volume":"223","author":"Tesmer","year":"2008","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.imbio.2021.152148_b0340","doi-asserted-by":"crossref","first-page":"e29062","DOI":"10.1371\/journal.pone.0029062","article-title":"Curative effect of 18\u03b2-glycyrrhetinic acid in experimental visceral leishmaniasis depends on phosphatase-dependent modulation of cellular MAP kinases","volume":"6","author":"Ukil","year":"2011","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.imbio.2021.152148_b0345","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGF\u03b2 in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.imbio.2021.152148_b0350","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrg3185","article-title":"Insights into the regulation of protein abundance from proteomic and transcriptomic analyses","volume":"13","author":"Vogel","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.imbio.2021.152148_b0355","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1002\/1521-4141(200212)32:12<3556::AID-IMMU3556>3.0.CO;2-Q","article-title":"The TGF-\u03b2 response to Leishmania chagasi in the absence of IL-12","volume":"32","author":"Wilson","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2021.152148_b0360","unstructured":"World Health Organization, 2010. Technical Report Series 949, Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22\u201326 March."},{"key":"10.1016\/j.imbio.2021.152148_b0365","author":"World Health Organization"},{"issue":"9","key":"10.1016\/j.imbio.2021.152148_b0370","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/eji.201040484","article-title":"A live Leishmania major vaccine containing CpG motifs induces the de novo generation of Th17 cells in C57BL\/6 mice","volume":"40","author":"Wu","year":"2010","journal-title":"Eur. J. Immunol."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298521000966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298521000966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:49:20Z","timestamp":1759250960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298521000966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0171298521000966"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2021.152148","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulatory role of Th17 pathway in experimental visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2021.152148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152148"}}